Low-dose ketamine improved brain network integrity among patients with treatment-resistant depression and suicidal ideation

IF 4.2 2区医学 Q1 PSYCHIATRY

Psychiatry Research Pub Date : 2025-01-26 DOI:10.1016/j.psychres.2025.116377

Tung-Ping Su , Li-Kai Cheng , Pei-Chi Tu , Li-Fen Chen , Wei-Chen Lin , Cheng-Ta Li , Ya-Mei Bai , Shih-Jen Tsai , Mu-Hong Chen

{"title":"Low-dose ketamine improved brain network integrity among patients with treatment-resistant depression and suicidal ideation","authors":"Tung-Ping Su , Li-Kai Cheng , Pei-Chi Tu , Li-Fen Chen , Wei-Chen Lin , Cheng-Ta Li , Ya-Mei Bai , Shih-Jen Tsai , Mu-Hong Chen","doi":"10.1016/j.psychres.2025.116377","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Ketamine is a dissociative drug used for the treatment of depression. However, the neurofunctional mechanism underlying the antidepressant effect of ketamine remains unknown. According to previous research, low-dose ketamine affects large-scale brain networks, including default-mode and salient networks.</div></div><div><h3>Methods</h3><div>A total of 43 patients with treatment-resistant depression (TRD) and suicidal ideation (SI) were randomly assigned to receive a single infusion of either 0.5 mg/kg ketamine or 0.045 mg/kg midazolam. Depressive and suicidal symptoms were evaluated using the 17-item Hamilton Depression Rating Scale and the Columbia–Suicide Severity Rating Scale: Ideation Severity Subscale. Resting-state functional magnetic resonance imaging was performed at baseline and on day 3 after infusion. Graph theoretic metrics such as degree centrality and clustering coefficient were examined.</div></div><div><h3>Results</h3><div>Relative to midazolam use, low-dose ketamine infusion reduced depressive (<em>p</em> = 0.001) and suicidal (<em>p</em> = 0.025) symptoms and improved the brain network integrity, including increased degree centrality and clustering coefficient in the angular gyrus and increased degree centrality in the right thalamus.</div></div><div><h3>Discussion</h3><div>Neurofunctional changes in the thalamus and default-mode network (angular gyrus) may be associated with the antidepressant effect of ketamine on patients with TRD and SI.</div></div><div><h3>Clinical trials registration</h3><div>UMIN Clinical Trials Registry (UMIN-CTR): Registration number: UMIN000033916.</div></div>","PeriodicalId":20819,"journal":{"name":"Psychiatry Research","volume":"345 ","pages":"Article 116377"},"PeriodicalIF":4.2000,"publicationDate":"2025-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatry Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0165178125000265","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Ketamine is a dissociative drug used for the treatment of depression. However, the neurofunctional mechanism underlying the antidepressant effect of ketamine remains unknown. According to previous research, low-dose ketamine affects large-scale brain networks, including default-mode and salient networks.

Methods

A total of 43 patients with treatment-resistant depression (TRD) and suicidal ideation (SI) were randomly assigned to receive a single infusion of either 0.5 mg/kg ketamine or 0.045 mg/kg midazolam. Depressive and suicidal symptoms were evaluated using the 17-item Hamilton Depression Rating Scale and the Columbia–Suicide Severity Rating Scale: Ideation Severity Subscale. Resting-state functional magnetic resonance imaging was performed at baseline and on day 3 after infusion. Graph theoretic metrics such as degree centrality and clustering coefficient were examined.

Results

Relative to midazolam use, low-dose ketamine infusion reduced depressive (p = 0.001) and suicidal (p = 0.025) symptoms and improved the brain network integrity, including increased degree centrality and clustering coefficient in the angular gyrus and increased degree centrality in the right thalamus.

Discussion

Neurofunctional changes in the thalamus and default-mode network (angular gyrus) may be associated with the antidepressant effect of ketamine on patients with TRD and SI.

Clinical trials registration

UMIN Clinical Trials Registry (UMIN-CTR): Registration number: UMIN000033916.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Psychiatry Research 医学-精神病学

CiteScore

17.40

自引率

1.80%

发文量

527

审稿时长

57 days

期刊介绍： Psychiatry Research offers swift publication of comprehensive research reports and reviews within the field of psychiatry. The scope of the journal encompasses: Biochemical, physiological, neuroanatomic, genetic, neurocognitive, and psychosocial determinants of psychiatric disorders. Diagnostic assessments of psychiatric disorders. Evaluations that pursue hypotheses about the cause or causes of psychiatric diseases. Evaluations of pharmacologic and non-pharmacologic psychiatric treatments. Basic neuroscience studies related to animal or neurochemical models for psychiatric disorders. Methodological advances, such as instrumentation, clinical scales, and assays directly applicable to psychiatric research.